Thyroid tumor

Related records

Broader conditions (10)

• Cancer or benign tumor
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Endocrine gland neoplasm
• Endocrine system disorder
• Human disease
• Neoplasm
• Neoplastic disease or syndrome
• Thyroid gland disorder

Narrower conditions (52)

• Benign thyroid gland neoplasm
• Columnar cell variant thyroid gland papillary carcinoma
• Differentiated thyroid carcinoma
• Familial medullary thyroid carcinoma
• Familial nonmedullary thyroid carcinoma
• Familial papillary or follicular thyroid carcinoma
• Familial papillary thyroid carcinoma with renal papillary neoplasia
• Familial thyroglossal duct cyst
• Follicular thyroid adenoma
• Intrathyroid thymic carcinoma
• Malignant thyroid stimulating hormone producing neoplasm of pituitary gland
• Medullary thyroid gland carcinoma
• Multicentric papillary thyroid carcinoma
• Multiple endocrine neoplasia type 2
• Multiple endocrine neoplasia type 2A
• Multiple endocrine neoplasia type 2B
• Papillary thyroid Microcarcinoma
• Tall cell variant thyroid gland papillary carcinoma
• Thyroid cancer
• Thyroid cancer, nonmedullary, 1

Trials (795)

• 11C-Acetate PET/CT Non-FDG-Avid Tumors
• 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
• 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
• 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
• 3-D Super Resolution Ultrasound Microvascular Imaging
• 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
• A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
• A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer
• A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
• A Deep Learning Method to Predict Difficult Laryngoscopy Using Cervical Spine X-ray Image
• A Follow-up Study of Women Evaluated and Treated for Infertility
• A Gene Hunting Study for Familial Papillary Thyroid Cancer
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
• A Multicenter Phase II Pilot Open Label
• A Multicenter Trial of PLA vs. Surgery for Treating PTMC
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)
• A New Surgical Strategy to Protect the Inferior Parathyroid
• A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer
• A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Approved drugs (6)

• Cabozantinib S-malate
• Lenvatinib mesylate
• Liothyronine sodium
• Selpercatinib
• Thyrotropin alfa
• Vandetanib

Drugs in development (10)

• Alectinib Phase 2
• Axitinib Phase 2
• Fimepinostat Phase 2
• Iodine Phase 3
• Lenalidomide Phase 2
• Pentetic acid Phase 2
• Ponatinib Phase 2
• Sorafenib Phase 3
• Technetium TC 99M pentetate Phase 2
• Valproic acid Phase 2

Other linked drugs (6)

• Cabozantinib
• Calcium carbonate
• Catequentinib
• Catequentinib hydrochloride
• Ergocalciferol
• Lenvatinib